Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose aspirin for ovulation induction success in women with polycystic ovary syndrome
IRCT20221112056477N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Jan 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of aspirin in polycystic ovary syndrome (PCOS), sponsored by Kurdistan University of Medical Sciences. Started Jan 2023; status: completed.
02
Drugs
aspirin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20221112056477N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221112056477N1.